The effects of omeprazole on polymorphonuclear neutrophil (PMN) chemotaxis, superoxide generation, degranulation and translocation of cytochrome b-245 were investigated. Omeprazole (106-5x0X-3 mol/l) reduced chemotaxis under agarose in a dose dependent manner, and the effect was irreversible. Superoxide anion generation was inhibited 50% at a concentration of 255X 0-5 mol/l and completely abolished at 5X 10-3 mol 1. Acid degraded omeprazole also inhibited 02 generation. Omeprazole did not scavenge 02 generated in a celi free xanthin-xanthine oxidase system. Degranulation by PMNs was inhibited only by omeprazole in concentrations above 10-4 moW. Translocation of cytochrome b-245, essential for generation of 02-, was not affected by omeprazole. In conclusion, the anti-ulcer agent omeprazole in concentrations obtained during intravenous administration may inhibit the function of PMNs in vitro.
Omeprazole (5-methoxy-2-(((4-methoxy-3,5-dimethyl -2 -pyridinyl) me -thyl) sulphinyl) -1H-benzimidazol) is a new anti-pulcer agent presently under extensive investigation. A1 Omeprazole is an inhibitor of the H+,K+-ATPase in the secretory membrane of the parietal cell2 3 and accumulates by a mechanism that is dependent on the acid environment. 4 Only few other cells generate a low pH and one of these is the polymorphonuclear neutrophilic granulocyte (PMN).
Activation of PMNs by chemotactic factors or during phagocytosis is followed by metabolic activation, secretion of H+ into the phagolysosome, and alkalinisation of the internal pH.5-'
The response to activation depends on a H+,Na+ exchange, phosphorylation of a membrane associated complex,'0 and a membrane bound H+-ATPase." 12 Translocation of a cytochrome b 245 from granules to the membrane initiates nicotinamide-adenine-dinucleotide phosphate (NADPH)-oxidase activity and the production of super oxide anion (02-) and oxygen radicals assumed to be important for intracellular bacterial killing and tissue damage. 13 It is possible that omeprazole can accumulate in PMNs and affect their function. The present investigation describes the effects of omeprazole on neutrophil function (chemotaxis, degranulation), production of 02-, and translocation of cytochrome b-245 from the granules to the cell membrane.
Methods
Omeprazole was donated by B Wallmark (Hassle, Molndal, Sweden). Dextrane T500 and Percoll were purchased from Pharmacia Fine Chemicals, formyl-methionine-leucinephenylalanine (FMLP), zymosan The slides were incubated in a humified atmosphere (90 minutes, 37°C, CO2 5%). The slides were then fixed in glutaraldehyde (2 5%; 18 hours), agarose was removed, and they were dryed. The distance migrated was measured after magnification (x 60) and the chemotactic response was given by the ratio between stimulated and unstimulated migration. Samples were measured in triplicate (interslide variation: 9%; intraslide variation 7%; no of experiments 12).
Generation of02
Ferricytochrome c reduction was used to measure the generation of 02 . ' PMNs in Ca++Mg++ buffer were incubated with omeprazole (30 minutes, 37°C) followed by the addition of cytochalasine B (2 [ig/ml). After five minutes the PMNs were isolated by centrifugation, resuspended in buffer without drug, 30 minutes) and resuspension in media without omeprazole reduced the chemotactic index to 61-65% and 53-63% of untreated control cells (n=3). When acid degraded omeprazole was used a similar inhibition was observed (Table I) . Spectroscopy Absorption spectra (440-600 nm; Cary 15) were measured after addition of triton x-100 (0.2%). The samples were divided and solid sodium hydrosulphite ( (Fig 1) . Omperazole reduced the distance migrated when both FMLP as well as ZAS were used as chemoattractants. Incuba- PMN generation of 02-was inhibited by omeprazole in a dose dependent manner (Fig 2) . There was 50% inhibition (IC50) at a concentration of 2.5 x10-5 mol/l.
Varying the time that the PMNs were incubated with omeprazole from 10 to 50 minutes showed the effect to be maximal after 30 minutes (10 minutes: 82%; 20 minutes: 62%; 30 minutes: 35%; 50 minutes: 34%; n=3)).
Quenching of 02-generated by omeprazole would mimick inhibition of ferricytochrome c reduction. A cell free xanthine-xanthine oxidase system was used to assess the effect of omeprazole alone. In this system omeprazole did not scavenge the 02-generated (2 x 10-4-5x 10-4 j 100- Generation of 02-was also measured after incubation ofPMNs with acid degraded omeprazole, imidazole, and 5.6-di-methyl-benzimidazole. Only acid degraded omeprazole (10-5-5x 10-4 mol/l) was found to inhibit 02-generation by 92 to 0% of control incubations. Imidazole or 5,6-di methylbenzimidazole had no effect in concentrations from 10-5 to 5 x 10-4 mol/l.
DEGRANULATION OF PMNS
Preincubation with omeprazole followed by activation of PMNs showed a diminished liberation of enzymatic activity into the medium in concentrations above 10`mol/1. The marker for cell damage (lactate dehydrogenase) remained low (control: 6% (range 5-8); omeprazole 5 x 10-4 mol/l: 5% (range 0-12) (Fig 3) .
TRANSLOCATION OF CYTOCHROME b_245
Nitrogen cavitation of PMNs and centrifugation on Percoll gradients results in three distinct bands. Table II gives the distribution of marker proteins. Fraction A contains the marker for membranes (alkaline phosphatase) and fractions B and C markers for granules (,B-glucuronidase, lysozyme, myeloperoxidase).
Spectroscopy of reduced versus non-reduced samples showed translocation of cytochrome b 245 from the granule fraction to the membrane fraction after activation. Figure 4 depicts the distribution of cytochrome b in resting, activated, and activated omeprazole treated PMNs. Incubation with omeprazole or polyethylene glycol 400 did not change the distribution of cytochrome b-245.
Discussion
The present study found that omeprazole inhibits PMN chemotaxis, degranulation, and 02 generation in concentrations that can be observed after intravenous administration of omeprazole.24 Similar studies have not been reported before. Omeprazole inhibited the response of PMNs in a concentration dependent fashion, with an IC50 of 2-5 x 10-5 mol/l. This is higher than the IC50 for the parietal cells (IC50: 5 x 10-6 mol/l). The differences in the IC50 required to affect PMNs and the parietal cells make a clinical effect unlikely during peroral administration since the plasma concentrations are low. However, during intravenous administration concentrations of 1-2x 10-5 mol/l are observed for a period of several hours.24 An effect in vivo is not unlikely considering the irreversibility of the in vitro effect observed in the present study.
Omeprazole is a substituted benzimidazole with a high affinity for intracellular compartments with an acid pH.4 In the acid environment the drug degrades and the activity is associated with the degradation products.425 The mode of action is inhibition of the parietal cell H+,K+-ATPase, causing a diminished proton secretion into the secretory canaliculus.34
The reasons for the present study were: (1) the affinity of omeprazole for acid environment and (2) 
